326 related articles for article (PubMed ID: 25460017)
1. Low level of hepatitis B virus screening among patients receiving chemotherapy.
Wi CI; Loo NM; Larson JJ; Moynihan TJ; Madde NR; Grendahl DC; Alberts SR; Kim WR
Clin Gastroenterol Hepatol; 2015 May; 13(5):970-5; quiz e51. PubMed ID: 25460017
[TBL] [Abstract][Full Text] [Related]
2. Testing for hepatitis B infection in prospective chemotherapy patients: a retrospective study.
Wang Y; Luo XM; Yang D; Zhang J; Zhuo HY; Zhang J; Jiang Y
World J Gastroenterol; 2013 Feb; 19(6):923-30. PubMed ID: 23429298
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus reactivation during anti-cancer chemotherapy in patients with past hepatitis B virus infection.
Kim E; Yune S; Ha JM; Lee WJ; Hwang JW; Paik YH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Hepatogastroenterology; 2014 Sep; 61(134):1704-11. PubMed ID: 25436366
[TBL] [Abstract][Full Text] [Related]
4. Low rates of hepatitis B virus screening at the onset of chemotherapy.
Hwang JP; Fisch MJ; Zhang H; Kallen MA; Routbort MJ; Lal LS; Vierling JM; Suarez-Almazor ME
J Oncol Pract; 2012 Jul; 8(4):e32-9. PubMed ID: 23180996
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.
Papadopoulos N; Deutsch M; Manolakopoulos S; Bitsi C; Michalakeas H; Poulakidas H; Tsironi E; Giannouli S; Papatheodoridis GV; Koskinas J; Pectasides D
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):56-60. PubMed ID: 27669175
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours.
Ling WH; Soe PP; Pang AS; Lee SC
Br J Cancer; 2013 May; 108(10):1931-5. PubMed ID: 23652302
[TBL] [Abstract][Full Text] [Related]
7. High hepatitis B virus screening rate among patients receiving systemic anticancer treatment in Japan.
Yazaki S; Yamauchi T; Higashi T
Int J Clin Oncol; 2020 Jul; 25(7):1327-1333. PubMed ID: 32200482
[TBL] [Abstract][Full Text] [Related]
8. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies.
Kawatani T; Suou T; Tajima F; Ishiga K; Omura H; Endo A; Ohmura H; Ikuta Y; Idobe Y; Kawasaki H
Eur J Haematol; 2001 Jul; 67(1):45-50. PubMed ID: 11553266
[TBL] [Abstract][Full Text] [Related]
9. Screening rate for hepatitis B virus infection in patients undergoing chemotherapy in Japan.
Ikeda M; Yamamoto H; Kaneko M; Oshima H; Takahashi H; Umemoto K; Watanabe K; Hashimoto Y; Ohno I; Mitsunaga S; Okusaka T
Int J Clin Oncol; 2016 Dec; 21(6):1162-1166. PubMed ID: 27260010
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
An J; Shim JH; Kim SO; Choi J; Kim SW; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
J Med Virol; 2016 Sep; 88(9):1576-86. PubMed ID: 26945543
[TBL] [Abstract][Full Text] [Related]
11. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen (HBSAG) seropositive cancer patients undergoing cytotoxic chemotherapy.
Cil T; Altintas A; Pasa S; Bayan K; Ozekinci T; Isikdogan A
Leuk Lymphoma; 2008 May; 49(5):939-47. PubMed ID: 18464113
[TBL] [Abstract][Full Text] [Related]
12. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis B and C virus infection and liver dysfunction in patients receiving chemotherapy].
Kwon CI; Lee JH; Choi KH; Ko KH; Hong SP; Hwang SG; Park PW; Oh D; Rim KS; Kim S
Korean J Gastroenterol; 2006 Dec; 48(6):408-14. PubMed ID: 17189924
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment.
Voican CS; Mir O; Loulergue P; Dhooge M; Brezault C; Dréanic J; Chaussade S; Pol S; Coriat R
Ann Oncol; 2016 Dec; 27(12):2172-2184. PubMed ID: 27803003
[TBL] [Abstract][Full Text] [Related]
15. A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.
Yağci M; Acar K; Sucak GT; Aki Z; Bozdayi G; Haznedar R
Leuk Lymphoma; 2006 Aug; 47(8):1608-12. PubMed ID: 16966273
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition.
Zhang X; Zhou Y; Chen C; Fang W; Cai X; Zhang X; Zhao M; Zhang B; Jiang W; Lin Z; Ma Y; Yang Y; Huang Y; Zhao H; Xu R; Hong S; Zhang L
J Immunother Cancer; 2019 Nov; 7(1):322. PubMed ID: 31753012
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver Diseases.
Hwang JP; Barbo AG; Perrillo RP
J Viral Hepat; 2015 Mar; 22(3):346-52. PubMed ID: 25220947
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy.
Fidan S; Fidan E; Alandağ C; Erkut M; Cosar AM
Arch Iran Med; 2020 Dec; 23(12):835-841. PubMed ID: 33356341
[TBL] [Abstract][Full Text] [Related]
20. A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
Long M; Jia W; Li S; Jin L; Wu J; Rao N; Feng H; Chen K; Deng H; Liu F; Su F; Song E
Breast Cancer Res Treat; 2011 Jun; 127(3):705-12. PubMed ID: 21445574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
